In addition to the presenter, following authors that helped with the content writing, review, or approval declare no conflict of interest.
Dr. Mobeen Syed
Dr. Pei Purdom
Dr. Beenish Zahra
Dr. Iqra Batool
Dr. Heba Alzawahri
Merck has a new drug molecule for SARS-COV-2. It is named Molnupiravir or EIDD-2801. We will discuss the following topics about this drug.
Mobeen Syed M.D, MS Graduated from King Edward Medical University. Entrepreneur, Medical Educator, CEO and founder of Drbeen corp.